9_98 Drug Schedules Regulation B.C.

· last amended 2025-12-15

Contents
s. 1 — Alphabetical order
s. 1(1)

The drug schedules are printed in an alphabetical format to simplify the process of locating each individual drug entry and determining its status in British Columbia.

s. 1(2)

Each entry is preceded by a code noted as 1, 1A, 2 or 3, in which

s. 2 — Sale of drugs
s. 2(1)

Drugs listed in Schedules I, IA, II and III must be sold from licensed pharmacies.

s. 2(2)

Unscheduled drugs may be sold from non-pharmacy outlets.

s. 2(3)

The various schedules are differentiated as follows:

Paragraph

Schedule I (Prescription): Schedule I drugs require a prescription for sale and are provided to the public by a pharmacist following the diagnosis and professional intervention of a practitioner. The sale is controlled in a regulated environment as defined by provincial pharmacy legislation. Entries followed by a "V" superscript may be sold without having received a prescription if Schedule IA (Triplicate/Duplicate Prescription Program): Drugs which may be sold by a pharmacist to a practitioner or on the prescription of a practitioner in accordance with the bylaws to the Pharmacy Operations and Drug Scheduling Act. Schedule II (Professional Service Area): Drugs which may be sold by a pharmacist on a non-prescription basis and which must be retained within the Professional Service Area of the pharmacy where there is no public access and no opportunity for patient self-selection. Schedule III (Professional Products Area): Drugs which may be sold by a pharmacist to any person from the self-selection Professional Products Area of a licensed pharmacy. Unscheduled (Non-pharmacy Sale): Drugs which may be sold by a non-pharmacist to any person.

(a)

the drug is in a form not suitable for human use, or

(b)

the main panel of the manufacturer's inner label and the manufacturer's outer label carry, in both official languages, the statement "For Veterinary Use Only" or "For Agricultural Use Only" immediately following or preceding the brand name, proper name or common name, in type size not less than one-half as large as the largest type on the label, and the product is sold in the original manufacturer's container.

s. 3 — Repealed

Repealed. [B.C. Reg. 418/98.]

s. 4 — Adoption of national drug lists
s. 4(1)

In this section:

s. 4(1) — National Drug Schedules

National Drug Schedules means the National Drug Schedules produced by the National Association of Pharmacy Regulatory Authorities;

s. 4(1) — Prescription Drug List

Prescription Drug List has the meaning given to it in section A.01.010 of the Food and Drug Regulations, C.R.C., c. 870.

s. 4(2)

Subject to section 5, the National Drug Schedules and the Prescription Drug List are adopted as follows:

s. 4(2)(a)

drugs that are listed in the Prescription Drug List or Schedule I of the National Drug Schedules are, if not listed in a Schedule to this regulation, deemed to be listed in Schedule I of this regulation;

s. 4(2)(b)

drugs that are listed in Schedule II of the National Drug Schedules are, if not listed in a Schedule to this regulation, deemed to be listed in Schedule II of this regulation;

s. 4(2)(c)

drugs that are listed in Schedule III of the National Drug Schedules are, if not listed in a Schedule to this regulation, deemed to be listed in Schedule III of this regulation.

s. 4(3)

For the purposes of section 22 (3) and (4) of the Pharmacy Operations and Drug Scheduling Act,

s. 4(3)(a)

the National Association of Pharmacy Regulatory Authorities is a body approved by the board, and

s. 4(3)(b)

the Prescription Drug List and the National Drug Schedules are adopted as amended from time to time.

s. 5 — Exception

Section 4 (2) does not apply to a drug listed in the table below.

Schedule

Schedules [am. B.C. Regs. 9/98; 141/98; 418/98; 247/99; 31/2000; 355/2000; 377/2000; 378/2000; 132/2001; 211/2001; 312/2001; 21/2002; 210/2002; 232/2002; 233/2002; 288/2002; 19/2003; 303/2003; 142/2006; 169/2006; 137/2007; 200/2008; 45/2009; 46/2009; 286/2009; 2/2011; 64/2011; 189/2011; 190/2011; 192/2012; 180/2015; 181/2015; 83/2016; 160/2016; 230/2016; 279/2016; 6/2017, s. (b); 137/2018; 261/2018; 9/2019; 135/2019; 1/2020; 292/2021, s. 2; 106/2022; 227/2022; 102/2023; 151/2023, s. 3; 236/2023; 15/2024; 174/2024; 100/2025; 137/2025; 238/2025.]